<DOC>
	<DOC>NCT02200094</DOC>
	<brief_summary>This study is designed to supplement, under conditions of usual clinical practice, the data on the efficacy and safety of Micardis® collected during the clinical studies.</brief_summary>
	<brief_title>Micardis®. Observational Study in Patients With Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Patients of either sex over the age of 18 years suffering from essential hypertension requiring treatment according to the physician Hypersensitivity to the active component or to any of the excipients Pregnancy and lactation Biliary obstructive disorders Severe hepatic impairment Severe renal impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>